Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 607-520-2 | CAS number: 250640-08-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: LD50 > 2000 mg/kg bw; Limit-Test, GLP, OECD Guideline Study, Safepharm Laboratories Ltd, 1235/003, 1998.
The test substance is virtually nontoxic after a single oral administration.
Acute dermal toxicity: LD50 > 2000 mg/kg bw; Limit-Test, GLP, OECD Guideline Study, Safepharm Laboratories Ltd, 1235/054, 1998
The test substance is virtually nontoxic after a single dermal application.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adopted 24 February 1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Sprague-Dawley (Crl : CD ® (SD) IGS BR)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd ., Margate, Kent, U.K.
- Age at study initiation: eight to twelve weeks.
- Weight at study initiation: males: 201 - 217g, females: 200 - 214g,
- Fasting period before study: overnight fast immediately before dosing and for approximately three to four hours after dosing
- Housing: up to five by sex in solid floor polypropylene cages furnished with woodflakes
- Diet: Rat and Mouse Expanded Diet No . 1, Special Diet Services Limited, Witham, Essex, U.K.), ad libitum
- Water: mains drinking water, ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 23
- Humidity (%): 54 - 67
- Air changes (per hr): approximately 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route of administration:
- oral: gavage
- Vehicle:
- other: distilled water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg / ml
- Amount of vehicle (if gavage): The volume administered to each animal was calculated according to its fasted bodyweight at the time of dosing.
- Justification for choice of vehicle: No data
DOSE VOLUME APPLIED: 10 ml / kg
DOSAGE PREPARATION (if unusual):
- For the purpose of the study the test material was freshly prepared, as required, as a solution at the appropriate concentration in distilled water.
- The concentration, homogeneity and stability of the test material preparations were not determined by analysis.
- Doses:
- 2000 mg/kg bodyweight
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- • Range-finding Study:
2000 mg / kg bodyweight were administered at a concentration of about 200 mg / mL at a dose volume of 10 mL / kg to one male and one female rat, respectively.
- Duration of observation period following administration: five days.
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity ½, 1 2, and 4 hours after dosing and subsequently once daily for five days. Individual bodyweights were recorded on the day of dosing to allow calculation of individual treatment volumes.
- Necropsy of survivors performed: no
There were no deaths or clinical signs of toxicity.
• Main Study:
Based on the information of the range-finding study, a dose level of 2000 mg / kg bodyweight was selected for the main study.
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed for deaths or overt signs of toxicity ½, 1, 2 and 4 hours after dosing and subsequently once daily for 14 days. Individual bodyweights were recorded prior to dosing on Day 0 and on Days 7 and 14.
- Necropsy of survivors performed: yes, at the end of the study the animals were killed by cervical dislocation and subjected to gross pathological examination. This consisted of an external examination and opening of the abdominal and thoracic cavities for examination of major organs. The appearance of any macroscopic abnormalities was recorded. No tissues were retained. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality. No signs of systemic toxicity.
- Mortality:
- There were no deaths.
- Clinical signs:
- other: No signs of systemic toxicity were noted during the study. The faeces of all animals was stained orange one and two days after treatment. The urine of all females was also stained orange during this period.
- Gross pathology:
- No abnormalities were noted at necropsy.
- Other findings:
- No other findings.
- Interpretation of results:
- GHS criteria not met
Reference
Table 1: Mean body weight |
|||
|
|
Mean |
SD |
Day 0 |
Males |
208.6 |
5.86 |
|
Females |
206.0 |
5.83 |
Day 7 |
Males |
269.2 |
9.68 |
|
Females |
238.0 |
8.80 |
Day 14 |
Males |
315.4 |
17.52 |
|
Females |
257.2 |
11.82 |
Table 2: Body weight gain (g) during week |
|||
|
|
Mean |
SD |
Week 1 |
Males |
60.6 |
8.11 |
|
Females |
32.0 |
3.94 |
Week 2 |
Males |
46.2 |
8.93 |
|
Females |
19.2 |
3.90 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP - Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- adopted 24 February 1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Sprague-Dawley (Crl : CD ® (SD) IGS BR)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd ., Margate, Kent, UK
- Age at study initiation: eight to twelve weeks.
- Weight at study initiation: males: 205 - 218 g, females: 200 - 221 g,
- Fasting period before study: overnight fast immediately before dosing and for approximately three to four hours after dosing
- Housing: The animals were housed in suspended polypropylene cages furnished with woodflakes. The animals were housed individually during the 24-hour exposure period and in groups of five, by sex, for the remainder of the study.
- Diet: Rat and Mouse Expanded Diet No . 1, Special Diet Services Limited, Witham, Essex, UK), ad libitum
- Water: mains drinking water, ad libitum
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 21
- Humidity (%): 51 - 65
- Air changes (per hr): approximately 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 / 12 - Type of coverage:
- semiocclusive
- Vehicle:
- other: The test material was moistened with distilled water.
- Details on dermal exposure:
- TEST SITE
- On the day before treatment the back and flanks of each animal were clipped free of hair using veterinary dippers.
- Area of exposure: back and flanks
- % coverage: approximating to 10% of the total body surface area
- Type of wrap if used: A piece of surgical gauze was placed over the treatment area and semioccluded with a piece of self-adhesive bandage. The animals were caged individually for the 24-hour exposure period. Shortly after dosing the dressings were examined to ensure that they were securely in place.
REMOVAL OF TEST SUBSTANCE
- Washing: the bandage was carefully removed and the treated skin and surrounding hair wiped with cotton wool moistened with
distilled water to remove any residual test material.
- Time after start of exposure: 24h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg / kg bw
- Concentration (if solution): undiluted
- Constant volume or concentration used: yes - Duration of exposure:
- 24 h
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: once daily
- Frequency of weighing: prior to application of the test material on day 0 and on day 7 and 14.
- Necropsy of survivors performed: yes, animals were killed by cervical dislocation and subjected to gross pathological examination. This consisted of an external examination and opening of the abdominal and thoracic cavities. The appearance of any macroscopic abnormalities was recorded. No tissues were retained.
- Other examinations performed: clinical signs, body weight, test sites were examined for evidence of primary irritation and scored according to Draize J.H. (1977) "Dermal and Eye Toxicity Tests" In: Principles and Procedures for Evaluating the Toxicity of Household Substances, National Academy 01 Sciences, Washington DC p. 31. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality. No signs of systemic toxicity.
- Mortality:
- There were no deaths.
- Clinical signs:
- other: No signs of systemic toxicity were noted during the study. Orange-coloured staining caused by the test material was noted at the treated skin sites of all animals and prevented an evaluation of the degree of erythema on Day 1. No signs of skin irritation
- Gross pathology:
- No abnormalities were noted at necropsy.
- Other findings:
- Signs of toxicity (local):
On day 1, scoring for erythema due to orange staining was not possible. No signs of dermal irritation were detected until the end of the study.
Reference
Table 1: Mean body weight |
|||
|
|
Mean |
SD* |
Day 0 |
Males |
213.4 |
5.22 |
|
Females |
208.6 |
8.62 |
Day 7 |
Males |
256.6 |
18.37 |
|
Females |
221.6 |
9.29 |
Day 14 |
Males |
311.4 |
23.16 |
|
Females |
238 |
11.98 |
Table 2: Body weight gain (g) during week 1 and 2 |
|||
|
|
Mean |
SD* |
Week 1 |
Males |
43.2 |
15.91 |
|
Females |
13.0 |
3.61 |
Week 2 |
Males |
54.8 |
14.81 |
|
Females |
16.4 |
3.51 |
* standard deviation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Additional information
There are valid in vivo data available for the assessment of the acute oral and dermal toxicity of the test item.
Acute Oral Toxicity
In the key study, performed as a limit test according to GLP and OECD Guideline 401 (Acute Oral Toxicity), fasted, 8 to 12 weeks old, Sprague Dawley rats (Crl : CD ® (SD) IGS BR, 5/sex/dose) were given a single oral dose (gavage) of the test item (analytical purity unknown) at a single dose of 2000 mg/kg bw (Safepharm Laboratories Ltd, 1235/003, 1989). The test item was diluted in distilled water at a concentration of 0.2 mg/mL and administered at a volume dosage of 10 ml/kg. The animals were observed subsequently for a period of 14 days. All animals were killed and subjected to gross pathology. No mortality occurred during the observation period. No signs of systemic toxicity were noted during the study. The faeces of all animals and the urine of all females were stained orange one to two days after treatment. All animals showed an expected gain in bodyweight during the study. No abnormalities were noted at necropsy.
Acute Dermal Toxicity
In the key study,performed as a limit test according to GLP and OECD Guideline 402 (Acute Dermal Toxicity), 8 to 12 weeks old Sprague Dawley rats (Crl : CD ® (SD) IGS BR, 5/sex/dose) were given a single semi-occluded dermal application at a dose level of the test item (analytical purity unknown) of 2000 mg/kg bodyweight (Safepharm Laboratories Ltd, 1235/054, 1989). The exposure period was 24 h and the observation period 14 days. No mortality occurred during the observation period. There were no signs of systemic toxicity or skin irritation during the study. There were no treatment related necropsy findings or changes in body weight.
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for the purpose of classification under Regulation (EC) No.1272/2008. No mortality occurred in rats treated with the limit dose in OECD testing guideline studies. Based on the data, classification for acute oral or dermal toxicity is not warranted under Regulation (EC) No.1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.